Small molecule modulators of mitochondrial Ca2+ uptake and efflux transporters, including MCU, MICU, and NCLX, have been developed and are in use for preclinical modeling in cancer, neurodegeneration, and cardiac research studies (discussed below). This evidence concerns the gene SLC8B1 and cancer.